Clinical Trial Evidence for Wegovy Wegovy approval was supported by large, randomized clinical trials, including the STEP 1 study: 1,961 adults with obesity or overweight plus weight-related health conditions 68-week study duration Average weight loss of approximately 14.9% of body weight 86% of participants lost at least 5% of body weight 69% lost at least 10% 50% lost at least 15% Participants followed reduced-calorie diets and increased physical activity Before receiving FDA approval, GLP-1 medications completed Phase I, Phase II, and Phase III trials
Thats understandable
(2021) 85:e13384
New Diagnosis of G6PD Deficiency Presenting as Severe Rhabdomyolysis. Cureus vol
While the researchers said the drug may contribute to a decrease in sexual desire due to its impact on hormones and neurological pathways, the specific process is unknown. Dr Naveed Asif , a GP from London General Practice, explained to The Guardian how these drugs can affect libido
Units Per Dose by Reconstitution Setup U-100 syringe units for each titration dose level, across the common vial and water combinations: * More than 100 units exceeds a full 1 mL U-100 syringe